Modulation of immunity and CEACAM1 activity
US11793894B2 · kind B2 · utility
0Cited by
3References
2Claims
0Family size
Inventor
Key dates
| Filing date | Jan 29, 2019 |
| Grant date | Oct 24, 2023 |
| Priority date | — |
| Expiry date | Apr 18, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70596
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present technology comprises methods for regulating an the immune system, and in particular methods for the regulation of a specific immune response, including the regulation of lymphocyte activity. Methods of the present technology comprise both the negative and positive modulation of CEACAM1 protein function.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.